I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Only the English text is available and authentic.
In electronic form on the EUR-Lex website under document number 32022M10874
Brussels, 20.12.2022 C(2022) 9972 final
DSM Venturing B.V. Het Overloon 1 6411 TE Heerlen The Netherlands
Fonterra (Europe) Coöperatie U.A. Barbara Strozzilaan 356-360 1083 HN Amsterdam The Netherlands
Dear Sir or Madam,
1.On 23 November 2022, the European Commission received notification of a proposed concentration pursuant to Article 4 of the Merger Regulation by which DSM Venturing B.V. (‘DSM’, the Netherlands), ultimately controlled by the Royal DSM N.V. group (‘Royal DSM’, the Netherlands), and Fonterra (Europe) Coöperatie U.A. (‘Fonterra’, the Netherlands), ultimately controlled by Fonterra Co-operative Group Limited (‘Fonterra Co-operative’, New Zealand), intend to acquire within the meaning of Articles 3(1)(b) and 3(4) of the Merger Regulation joint control of a newly created company constituting a joint venture, Tasman B.V. (‘JV’, the Netherlands), by way of purchase of shares.
The business activities of the undertakings concerned are the following:
- Fonterra is active in the production and sale of dairy products worldwide,
1OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’). With effect from 1 December 2009, the Treaty on the Functioning of the European Union (‘TFEU’) has introduced certain changes, such as the replacement of ‘Community’ by ‘Union’ and ‘common market’ by ‘internal market’. The terminology of the TFEU will be used throughout this decision.
2OJ L 1, 3.1.1994, p. 3 (the ‘EEA Agreement’).
3Publication in the Official Journal of the European Union No C 458, 1.12.2022, p. 13.
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË
Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.
- DSM is active in nutrition, health and bioscience providing nutritional solutions, specialty additives to nutritional segments, ingredients, biomedical materials as well as solutions that address taste and texture.
The JV will be active in the market for alternative proteins by developing and producing, marketing and selling fermentation-derived dairy protein.
4.After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger Regulation and of paragraph 5 (c) of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004.
For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article 6(1)(b) of the Merger Regulation and Article 57 of the EEA Agreement.
For the Commission
(Signed) Olivier GUERSENT Director-General
4OJ C 366, 14.12.2013, p. 5.
2